CMP Pharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CMP Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10614
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CMP Pharma Inc (CMP Pharma), formerly Carolina Medical Products Company Inc is a specialty pharmaceutical company that develops and manufactures generic prescription, non-prescription and skin care products. The company’s prescription products include SPS suspension, isoniazid oral solution USP, oracit, trianex, amantadine oral syrup, and others. Its non prescription drugs comprise simethicone drops and sorbitol solution USP, absorbase, dermacloud and petrolatum ointment base, among others. CMP Pharma’s SPS suspension is a suspension form of sodium polystyrene sulfonate for the treatment of hyperkalemia. The company offers treatment in the areas of hyperkalemia, influenza, tuberculosis, digestive tract and dermatologic infections. It operates its manufacturing facility in North Carolina, the US. CMP Pharma is headquartered in Farmville, North Carolina, the US.

CMP Pharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CMP Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CMP Pharma Enters into Agreement with Generic Specialty Pharma 10
CMP Pharma Partners with Kiel Labs 11
Licensing Agreements 12
Promius Pharma Enters into Licensing Agreement with CMP Pharma for Trianex 12
CMP Pharma Inc – Key Competitors 13
CMP Pharma Inc – Key Employees 14
CMP Pharma Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
CMP Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CMP Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CMP Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CMP Pharma Enters into Agreement with Generic Specialty Pharma 10
CMP Pharma Partners with Kiel Labs 11
Promius Pharma Enters into Licensing Agreement with CMP Pharma for Trianex 12
CMP Pharma Inc, Key Competitors 13
CMP Pharma Inc, Key Employees 14

List of Figures
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CMP Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CMP Pharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lycamobile UK Limited:企業の戦略的SWOT分析
    Lycamobile UK Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Soil Machine Dynamics Ltd:企業の戦略的SWOT分析
    Soil Machine Dynamics Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ajinomoto Co., Inc.:企業の戦略・SWOT・財務情報
    Ajinomoto Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Ajinomoto Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • BASF Mexicana SA de CV:企業の戦略的SWOT分析
    BASF Mexicana SA de CV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • TD Ameritrade Holding Corporation:企業の戦略・SWOT・財務情報
    TD Ameritrade Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary TD Ameritrade Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Solargiga Energy Holdings Ltd (757):電力:M&Aディール及び事業提携情報
    Summary Solargiga Energy Holdings Ltd (Solargiga Energy), a subsidiary of Wafer Works Corp is a renewable energy equipment manufacturer that develops and markets monocrystalline silicon products. The company manufactures monocrystalline silicon solar ingots and wafers, solar cells and photovoltaic m …
  • Annexon Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Annexon Inc (Annexon) is a developer of therapeutic products and pathway inhibitors for the treatment of neurological disorders. The company develops treatments for Huntington’s disease and Alzheimer’s disease by targeting complement-mediated neurodegeneration. Its lead drug candidates inclu …
  • Emzor Pharmaceutical Industries Ltd:企業の戦略的SWOT分析
    Emzor Pharmaceutical Industries Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Event Hospitality & Entertainment Ltd:企業の戦略・SWOT・財務情報
    Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Faroe Petroleum plc (FPM):企業の財務・戦略的SWOT分析
    Summary Faroe Petroleum Plc (Faroe Petroleum) is an oil and gas company that concentrates on exploration, appraisal, development and production opportunities. The company has its exploration and development assets in the UK. Its operations portfolio consists of exploration, appraisal, development an …
  • Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析
    Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sanmina Corporation (SANM):企業の財務・戦略的SWOT分析
    Sanmina Corporation (SANM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Bumi Armada Bhd (ARMADA):石油・ガス:M&Aディール及び事業提携情報
    Summary Bumi Armada Bhd (Bumi Armada) is an integrated offshore solutions provider. The company owns and operates Floating Production Storage & Offloading (FPSO), Offshore Support Vessels (OSV), pipelaying barges, and subsea vessels. Its FPSO portfolio includes Armada TGT 1, Armada Sterling, Armada …
  • Nippon Express Co Ltd (9062):企業の財務・戦略的SWOT分析
    Nippon Express Co Ltd (9062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Asklepios Biopharmaceutical Inc (AskBio) is a biotechnology company that develops and markets novel protein and cellular based therapies. The company has developed library of rAAV biological nano particles that provides unsurpassed transduction. Its products include such as biostrophin, AskB …
  • API Group plc:企業の戦略・SWOT・財務情報
    API Group plc - Strategy, SWOT and Corporate Finance Report Summary API Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • MGM Resorts International:企業のM&A・事業提携・投資動向
    MGM Resorts International - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MGM Resorts International Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Agenus Inc (AGEN):企業の財務・戦略的SWOT分析
    Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Abreos Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Abreos Biosciences Inc (Abreos) is a biotechnology company with focus on the development of laboratory-based and point-of-care (POC) assays and reagents for the precision dose monitoring of biologic drugs. Its Monator, is a drug-monitoring test that provides physicians with vital information …
  • Gland Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Gland Pharma Ltd (Gland Pharma) is a healthcare products provider that develops and manufactures active pharmaceutical ingredients. The company’s products include injectables, pre filled syringes, vials, ampoules, infusions, ophthalmic solutions, lyophilized vials, dry powders, lyophilized p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆